Searchable abstracts of presentations at key conferences in endocrinology

ea0034p342 | Steroids | SFEBES2014

Monitoring outcomes in congenital adrenal hyperplasia: have we been neglecting testosterone?

Sakai Naomi , Acerini Carlo

Background: Congenital adrenal hyperplasia (CAH) is a group of disorders caused by defects in one of the enzymes in the adrenal steroidigenic pathways. The most common form is 21-hydroxylase deficiency which leads to decreased production of cortisol and aldosterone and increased androgen production. Close monitoring of treatment is important so that adrenal suppression is achieved without excessive exposure to glucocorticoids. The current gold standard for monitoring in CAH is...